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ABSTRACT
The advent of high-throughput measurements of gene expression and bioinformatics analysis methods offers new ways to study gene
expression patterns. The primary goal of this study was to determine the time sequence for gene expression in a bone subjected to
mechanical loading during key periods of the bone-formation process, including expression of matrix-related genes, the appearance of
active osteoblasts, and bone desensitization. A standard model for bone loading was employed in which the right forelimb was loaded
axially for 3minutes per day, whereas the left forearm served as a nonloaded contralateral control. We evaluated loading-induced gene
expression over a time course of 4hours to 32 days after the first loading session. Six distinct time-dependent patterns of gene
expression were identified over the time course and were categorized into three primary clusters: genes upregulated early in the time
course, genes upregulated during matrix formation, and genes downregulated during matrix formation. Genes then were grouped
based on function and/or signaling pathway. Many gene groups known to be important in loading-induced bone formation were
identified within the clusters, including AP-1-related genes in the early-response cluster, matrix-related genes in the upregulated gene
clusters, and Wnt/b-catenin signaling pathway inhibitors in the downregulated gene clusters. Several novel gene groups were identified
as well, including chemokine-related genes, which were upregulated early but downregulated later in the time course; solute carrier
genes, which were both upregulated and downregulated; and muscle-related genes, which were primarily downregulated.  2011
American Society for Bone and Mineral Research.
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Introduction
B
one responds in an anabolic manner to physiologic dynamic
loading. For example, the midshaft humerus in the throwing
arm of baseball pitchers and catchers showed enhanced bone
mass, structure, estimated strength, and resistance to torsion
compared with the nonthrowing control arm.
(1) In contrast, bone
mineral density (BMD) in astronauts decreased 1.0% and 1.5% in
the spine and hip, respectively, per month of spaceflight.
(2,3)
Mechanical loading is a potent anabolic stimulus that
substantially strengthens bones. Using the rat forelimb loading
model, we showed that loading for only 3minutes/day over
16 weeks doubled the energy necessary to break the ulna
(4) and
increased the fatigue life of the bone by 100-fold.
(5) Mechanical
loadingusespathwayscurrentlybeinginvestigatedfornewdrug
development, such as low density lipoprotein receptor–related
protein 5 (LRP5) and sclerostin.
(6) Others have proposed that the
mechanical loading response is fundamental to bone biology,
andmanydrugsworkbymodulatingtheresponsiveness ofbone
to loading.
(7) Hence, we believe that mechanical loading can be
used as a paradigm for bone anabolism. This approach has the
advantage of producing a local response, so the contralateral
limb can be used as a control to compare with loading effects on
the loaded limb.
The time course of bone formation after initiating mechanical
loading is well characterized. New osteoblasts appear on the
bone surface 24 to48hoursafter initiatingmechanical loading,
(8)
and bone formation is observed within 96hours of loading.
(9)
Bone formation increases between 5 and 12 days after starting
loading,
(9) but after 6 weeks of loading, bone formation returns
tobaselinelevels.
(10)Thesedataindicatethatappliedmechanical
loading to bone results in osteoblast recruitment followed by
matrix production, which lasts for around 5 weeks before
declining to baseline levels.
(11) Mechanical loading affects
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100signaling pathways and gene expression in loaded bone,
(12,13) so
we hypothesize that the gene expression patterns are time-
dependent, with early activities stimulating a chain reaction of
events that directly affects bone cell behavior and ultimately
leads to bone formation.
The primary goal of this study was to determine the time
sequence for gene expression in a bone subjected to mechanical
loading. We evaluated loading-induced gene expression over a
time course of 4hours to 32 days. We then used bioinformatics
tools to cluster genes into similar expression patterns and group
genes within common signaling pathways.
Materials and Methods
Animals
Adult female Lewis rats were purchased from Charles River
Laboratories, Inc. (Wilmington, MA, USA). The animals were fed
standard rat chow and water ad libitum and acclimated until
20weeksofage(averageweightof209.1 12.5g).Animalswere
divided into 11 groups: 4hours (n¼9), 12hours (n¼10), 1 day
(n¼9), 2 days (n¼10), 4 days (n¼10), 6 days (n¼10), 8 days
(n¼8), 12 days (n¼7), 16 days (n¼9), 24 days (n¼11), and
32 days (n¼12). All procedures were performed in accordance
with the Institutional Animal Care and Use Committee guidelines
of Indiana University.
Mechanical loading
A standard model for bone loading was employed in which the
right forelimb was loaded axially for 3minutes per day while the
left forearm served as a nonloaded contralateral control.
(4,14,15)
Prior to loading, animals were anesthetized with 3.0% isoflurane
administered at a flow rate of 1.5 L/min. Compressive load was
applied as an oscillating Haversine waveform for 360 cycles at a
frequency of 2Hz using a Bose ElectroForce 3200 Series
electromechanical actuator (EnduraTEC, Eden Prairie, MN,
USA). The peak load achieved during loading was 13N, which
has been shown previously to be anabolic.
(14) Rats were
subjected to loading sessions every day with 24hours between
sessions. The study groups listed earlier are referenced to the
numberofdays(orhours)afterthefirstboutofboneloadingwas
applied. At the appropriate time point, animals were anesthe-
tized with isoflurane and euthanized by cervical dislocation.
Histology
Nine additional adult female Lewis rats were subjected to the
loading protocol for histologic analysis. These rats were
euthanized 1 and 4 days after beginning loading. The shafts
of the right and left forearms with intact ulnae and radii were
dissected, freed of excess muscle, and fixed in 10% neutral
buffered formalin (NBF) for 48hours. The fixed forearms were
decalcified in a 70:30 solution of 10% ethylenediamine
tetraacetic acid (EDTA) and 4% phosphate-buffered formalin
(PBF)for4weeks.Afterdecalcification,forearmswereembedded
in paraffin and sectioned at the ulnar midshaft at 4mm. Sections
were stained with hematoxylin and eosin (H&E) and used to
identify active osteoblasts on the periosteal surfaces of loaded
ulnae. Active osteoblasts were counted and defined as
osteoblast cell bodies that were plump and present in the layer
of cells immediately adjacent to newly formed osteoid on the
bone surface. The sections were photographed on a Nikon
Optiphot-2 microscope (Nikon, Inc., Melville, NY, USA) using 5 
and 40  objectives and imported into Image-Pro Plus 6.3
(MediaCybernetics, Inc., Bethesda, MD, USA) analysis software for
quantification. Total perimeter of the periosteal surface was
measured, and average osteoblast number per total bone
perimeter (mm, Ob.N/B.Pm) was reported.
RNA isolation
The shafts of the right and left ulnae were dissected, freed of all
soft tissue, and snap frozen in liquid nitrogen. The ulnae were
stored at –808C until RNA isolation. RNA was extracted using
Trizol (Invitrogen, Carlsbad, CA, USA) and RNeasy Mini Kits
(Qiagen, Inc., Valencia, CA, USA). Frozen ulnae were placed into a
mortar containing liquid nitrogen and crushed with a pestle. The
crushed bone was homogenized in Trizol, incubated, and
centrifuged. Thesupernatant was removed, and RNeasy Mini Kits
were used to isolate RNA. RNA was treated with a DNA-free kit
(Ambion, Austin, TX, USA) to remove any residual DNA. RNA
quality and quantity were determined using a spectrophot-
ometer (NanoDrop, Wilmington, DE, USA). A paired t test was
used to compare average total RNA quantity obtained from
loaded and control bones for each time group. Average RNA
quantity and standard errors were reported, and a p value<.05
was considered statistically significant.
Quantitative polymerase chain reaction (qPCR)
Three matched RNA samples from loaded and control ulnae for
each time group were used for quantitative real-time PCR (qPCR)
experiments. RNA was reverse transcribed using the SuperScript
III kit with oligo(dT) primers (Invitrogen). cDNA was diluted to a
concentration of 2.5ng/mL and used in qPCR reactions. Aportion
of the rat collagen type 1a1 (Col1a1) gene sequence was
amplified using a Taqman gene expression assay (assay ID:
Rn01463848_m1, Applied Biosystems, Inc., Carlsbad, CA, USA).
Serial dilutions of a single sample were amplified to calculate
relative expression levels, which then were standardized to b-
actin expression to facilitate comparison among samples. The
reactions were performed on an ABI 7900HT Fast Real-Time PCR
System (Applied Biosystems). A paired t test was used to
compare Col1a1 expression in loaded and control conditions.
Average fold change and standard errors were reported, and
p<.05 was considered statistically significant.
Exon arrays
The array methodology is summarized in a flow diagram (Fig. 1).
Quality-control measures were employed to ensure that high-
quality RNA would be hybridized to exon arrays. A high-quality
RNA sample was defined as having a minimum 260:280 ratio of
2.00. Four RNA samples had a 260:280 ratio of slightly less than
2.00, and these samples were chosen to optimize the quantity of
total RNA as well as the quality. The range of 260:280 ratios of all
samples used was 1.96 to 2.31.
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each time group were used for exon array analysis. One
exceptiontothiswasthe12-daygroup,whereonlyfourmatched
samples were used. RNA from the control and loaded ulnae from
54 animals were analyzed on separate arrays. The exon array
hybridizations were carried out using the facilities of the
Center for Medical Genomics (CMG) at Indiana University
School of Medicine. One microgram of each sample was labeled
and hybridized using the Affymetrix WT protocol [GeneChip
Whole Transcript (WT) Sense Target Labeling Assay Manual,
Version 4, Affymetrix, Santa Clara, CA, USA]. All processing was
done in balanced batches. The exon arrays were scanned using
the GeneChip Scanner 3000 using the Affymetrix GeneChip
Operating System (GCOS). Data were exported for analysis in the
Partek Genomics Suite (Partek, Inc., St. Louis, MO, USA).
The robust multiarray average(RMA) algorithm
(16–18) wasused
to import raw data from the core probe sets, which represented
over 8000 genes. A two-way ANOVA model [variables were
loading condition (loaded or control) and animal] was used to
identify differentially expressed genes, which were defined as
having p<.01 and fold change beyond  1.4. Probe sets with a
signal value of less than 3 were not reliable and were excluded
from analysis. Raw data and analyzed data were MIAME-
compliant
(19) and were deposited in the Gene Expression
Omnibus database (series accession number GSE22286).
Clustering analysis
Differentially expressed genes were further analyzed with a k-
means (ie, partitioning) clustering algorithm. The inclusion
criterion for a gene to qualify for clustering analysis was that the
genemustbedifferentiallyexpressedataminimumofoneofthe
11 time points.
Functional characterization
Groups of genes then were defined based on gene and
associated protein function using Ingenuity Pathways Analysis
(IPA, Ingenuity Systems, Redwood City, CA, USA, www.ingenuity.
com). IPA uses information about gene relationships from the
literature to characterize gene sets, create gene networks, and
identify important signaling pathways in gene expression data.
Results
Histology
H&E-stained sections through the ulnar midshaft were used to
count osteoblasts and look for evidence of bone formation
(Fig. 2). There were no osteoblasts on the periosteal surface of
controlulnaeateither1or4daysafterloading.Someosteoblasts
werepresentontheperiostealsurfaceofasingleloadedboneon
1 day, but no active osteoblasts were observed in any other
loaded bones on 1 day. The average Ob.N/B.Pm was 2.22 4.97
for the loaded bones 1 day after loading. The most remarkable
results were in loaded bones in the 4-day group. Osteoid was
observed on the periosteal surface of loaded bones, which
indicated that new bone was being formed. In addition, active
osteoblasts were present and the average Ob.N/B.Pm was
33.1 6.6 for loaded bones at 4 days. Osteoclasts were not
observed in any of the bone sections.
Total RNA
The total amount of RNA isolated from loaded bones was
significantly greater than the total amount of RNA isolated from
control bones for all time points except 2 days (Fig. 3). Total RNA
increased substantially from 4 to 8 days in the loaded bones, and
then the amount declined from 12 to 32 days.
Col1a1 expression
qPCR was used to measure Col1a1, a major bone matrix gene, to
characterize matrix synthesis.
(20–22) Figure 4 shows that Col1a1
gene expression began to increase in loaded ulnae at 4 days,
when active osteoblasts were present on the periosteal bone
surface (Fig. 2). Col1a1 expression peaked at 12 days in loaded
bones and declined toward baseline levels at later time points.
Col1a1 expression was not changed in control ulnae. Since
Col1a1 expression corresponded with the observation of active
osteoblasts, we presume that osteoblasts were the primary
contributors to the qPCR signal for Col1a1. Furthermore, the
Col1a1 expression time course was very similar to the time
course of osteoblast recruitment and bone formation observed
by others.
(8–10)
Clustering analysis
The primary goal of the clustering analysis was to determine the
patterns of gene expression in bones subjected to mechanical
loading overatimesequence of4hoursto32days. Weidentified
1051 genes that were differentially expressed at a minimum of
one of the 11 time points. This gene list was analyzed using
k-means clustering. Six distinct patterns of differential gene
Fig. 1. Flow diagram of the array analysis methods.
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response cluster (blue line) in which the genes were upregulated
early but not late in the time course, three matrix-formation (up)
clusters (red lines) that followed the pattern of matrix synthesis
illustrated by expression of the Col1a1 gene (Fig. 4), and two
matrix-formation (down) clusters (green lines) that were down-
regulated during matrix formation. There were 88 genes in the
early-response cluster, and genes in this cluster were upregu-
lated early on, primarily at 4hours. There were 23 genes in the
matrix-formation (up) high-magnitude cluster, 182 genes in the
matrix-formation (up) medium-magnitude cluster, and 308
genes in the matrix-formation (up) low-magnitude cluster.
Genes in these three clusters were upregulated during matrix
formation, and expression reached peak levels between 12 and
16 days. There were 124 genes in the matrix-formation (down)
high-magnitude cluster and 326 genes in the matrix-formation
(down) low-magnitude cluster. Genes in these two clusters were
downregulated during matrix formation, and differential
expression was greatest at 16 days. Within each cluster of
genes, we identified groups of genes that have common
functions or are part of common pathways using IPA. The
completelistof1051genesisavailableinSupplementalTableS1.
Early-response cluster
Selected gene groups from the early-response cluster are listed
in Table 1 and included AP-1, calcium signaling, chemokine,
cytokine, and matrix. Of these, the chemokine group that was
upregulated within 12hours of loading was novel for bone
formation. Genes in the chemokine group included a binding
Fig. 2. Active osteoblasts were observed on the periosteal surface in H&E-stained cross sections of the loaded ulnar midshaft at 4 days. (Bottom) Cross
sections of representative loaded ulnae at 1 day (left) and 4 days (right)(  5). (Top) Close-up images of the periosteal surface on the medial side of loaded
ulnae at 1 day (left) and 4 days (right)(  40). Many active osteoblasts and osteoid were present on the bone surface at 4 days, which indicated that new
bone was being formed.
Fig. 3. The amount of total RNA isolated from loaded bones was sig-
nificantly greater than the amount of total RNA isolated from control
bones at all time points except 2 days. A paired t test was used to
compare RNA quantities in loaded and control ulnae from matched RNA
samples (
ap value<.05). Standard errors are indicated.
Fig. 4. Col1a1 expression increased in loaded ulnae at 1, 6, 8, 12, and 32
days. qPCR was used to evaluate Col1a1 gene expression in loaded and
control ulnae across the time course. Col1a1 expression was normalized
to b-actin expression to facilitate comparison among samples. A paired t
test was used to compare expression in loaded and control conditions
(
ap<.05). Standard errors are indicated.
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motif ligands (Cxcl1 and Cxcl13).
Matrix-formation (up) clusters
Expression of genes in the matrix-formation (up) clusters peaked
during the synthetic phase of bone formation. Several important
gene groups were identified and include apoptosis, calcium
signaling, cytokine, growth factor, ion channel, matrix, muscle,
neurotransmitter, solute carrier, transforming growth factor b
(TGF-b) signaling, and Wnt/b-catenin signaling (Table 2). The
matrix group included many of the expected genes associated
with bone formation, such as Alpl, Bglap, and Col1a2. Probes
targeting the Col1a1 gene were not detected on the exon array
and therefore Col1a1 is not reported in Table 2, but using qPCR,
we found that its expression followed a similar pattern (Fig. 4).
The solute carrier group represents a novel finding with respect
to bone mechanotransduction. This group includes transporters
for amino acids and many ions. Presumably, such transport is
necessary to facilitate the synthetic activity of osteoblasts.
Matrix-formation (down) clusters
Genes in the matrix-formation (down) clusters were down-
regulated during the synthetic phase of bone formation. Several
important gene groups were identified in these clusters and
include calcium signaling, cell cycle, chemokine, cytokine,
growth factor, ion channel, matrix, neurotransmitter, TGF-b
signaling, ubiquitin, and inhibitors of Wnt/b-catenin signaling
(Table 3). In particular, there were large groups of muscle and
solute carrier genes that were downregulated. Another
important finding in this cluster was that genes encoding
inhibitors of both TGF-b (Grem1 and Chrdl1) and Wnt/b-catenin
signaling (Sost and Sfrp4) were downregulated, supporting
observations that negative regulation of inhibitors was impor-
tant to enhance signaling through these pathways.
(21)
Discussion
We have identified six distinct patterns of gene expression, and
these were categorized into three primary clusters of genes:
Fig. 5. Six clusters were defined using a k-means clustering algorithm.
Genes in the early-response cluster (n¼88) were upregulated primarily
at 4 hours. Expression of genes in the matrix-formation (up) clusters
peaked between 12 and 16 days, and this cluster was subdivided into
three magnitudes: high (n¼23), medium (n¼182), and low (n¼308).
Expression of genes in thematrix-formation (down)clusters peaked at 16
days,andthisclusterwassubdividedintotwomagnitudes:high(n¼124)
and low (n¼326).
Table 1. Selected Gene Groups Present in the Early-Response
Cluster, Which Were Upregulated 4 Hours After a Single Loading
Session
Gene group Gene name
AP-1
Fosl1 Fos-like antigen 1
Junb Jun B protooncogene
Calcium signaling
Anxa2 Annexin A2
S100a4 S100 calcium-binding protein A4
S100a10 S100 calcium-binding protein A10
Chemokine
Ccbp2 Chemokine-binding protein 2
Ccl2 Chemokine (C–C motif) ligand 2
Ccl7 Chemokine (C–C motif) ligand 7
Cxcl1 Chemokine (C–X–C motif) ligand 1
Cxcl13 Chemokine (C–X–C motif) ligand 13
Cytokine
Il1rl1 Interleukin 1 receptor–like 1
Il1rl2 Interleukin 1 receptor–like 2
Osm Oncostatin M
Osmr Oncostatin M receptor
Socs3 Suppressor of cytokine signaling 3
Stat3 Signal transducer and activator of transcription 3
Tnfrsf12a Tumor necrosis factor receptor superfamily,
member 12A
Matrix
Adamts1 ADAM metallopeptidase with thrombospondin
type 1 motif
Ecm1 Extracellular matrix protein 1
Serpina3n Serine (or cysteine) peptidase inhibitor, clade A,
member 3N
Serpine1 Serpin peptidase inhibitor, clade E, member 1
Tfpi2 Tissue factor pathway inhibitor 2
Other
Ccnd2 Cyclin d2
Clic1 Chloride intracellular channel 1
Gpr1 G protein–coupled receptor 1
Kcne4 Potassium voltage-gated channel, Isk-related
subfamily, gene 4
Lep Leptin
Sdc4 Syndecan 4
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Gene group Cluster Gene name
Apoptosis
Aifm3 L Apoptosis-inducing factor, mitochondrion-associated 3
Bok L BCL2-related ovarian killer
Dad1 L Defender against cell death 1
Calcium signaling
Atp2b2 L ATPase, Ca
2þ transporting, plasma membrane 2
Cacnb3 M Calcium channel, voltage-dependent, b3 subunit
Cadps MC a
2þ-dependent secretion activator
Calu M Calumenin
Capn6 M Calpain 6
Flvcr2 L Feline leukemia virus subgroup C cellular receptor family, member 2
Hpcal1 L Hippocalcin-like 1
Stc1 L Stanniocalcin 1
Syt3 L Synaptotagmin III
Cytokine
Il4 L Interleukin 4
Il11 L Interleukin 11
Il12a M Interleukin 12a
Socs2 L Suppressor of cytokine signaling 2
Growth factor
Fgf14 L Fibroblast growth factor 14
Pdgfa L Platelet-derived growth factor a polypeptide
Pdgfc M Platelet-derived growth factor C
Pdgfrl M Platelet-derived growth factor receptor–like
Pgf L Placental growth factor
Ion channel
Kcne3 M Potassium voltage-gated channel, Isk-related subfamily, gene 3
Kcng3 L Potassium voltage-gated channel, subfamily G, member 3
Kcnk6 M Potassium inwardly rectifying channel, subfamily K, member 6
Kcnma1 M Potassium large conductance calcium-activated channel, subfamily M, a member 1
Kcnn2 M Potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2
Kcns1 L Potassium voltage-gated channel, delayed-rectifier, subfamily S, member 1
Scn1a L Sodium channel, voltage-gated, type I, a
Matrix
Acan H Aggrecan
Alpl M Alkaline phosphatase, liver/bone/kidney
Bglap M Bone g-carboxyglutamate (gla) protein (osteocalcin)
Bgn M Biglycan
Col1a2 M Collagen, type I, a2
Col2a1 M Collagen, type II, a1
Col3a1 M Collagen, type III, a1
Col5a1 H Collagen, type V, a1
Col11a2 H Collagen, type XI, a2
Col16a1 M Collagen, type XVI, a1
Cthrc1 H Collagen triple-helix-repeat-containing 1
Efemp2 L EGF-containing fibulin-like extracellular matrix protein 2
Fn1 M Fibronectin 1
Ibsp M Integrin-binding sialoprotein
Lepre1 H Leucine proline–enriched proteoglycan (leprecan) 1
Lox H Lysyl oxidase
Mmp2 M Matrix metallopeptidase 2
Mmp9 M Matrix metallopeptidase 9
Mmp14 M Matrix metallopeptidase 14
Mmp16 M Matrix metallopeptidase 16
Mmp23 M Matrix metallopeptidase 23
Omd M Osteomodulin
P4ha1 M Procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), a polypeptide I
P4ha3 M Procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), a polypeptide III
P4hb M Prolyl 4-hydroxylase, b polypeptide
Pcolce M Procollagen C-endopeptidase enhancer
Plod2 M Procollagen lysine, 2-oxoglutarate 5-dioxygenase 2
(Continued)
GENE EXPRESSION IN BONE Journal of Bone and Mineral Research 105Table 2. (Continued)
Gene group Cluster Gene name
Plod3 M Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3
Sparc L Secreted protein, acidic, cysteine-rich (osteonectin)
Timp1 H TIMP metallopeptidase inhibitor 1
Vcan H Versican
Muscle
Myo1b M Myosin Ib
Myo5a M Myosin Va
Tpm4 L Tropomyosin 4
Tuba3a L Tubulin, a3A
Neurotransmitter
Drd1a L Dopamine receptor D1A
Glrb L Glycine receptor, b
Htr1d L 5-Hydroxytryptamine (serotonin) receptor 1D
Htr2a M 5-hydroxytryptamine (serotonin) receptor 2A
Syn1 L Synapsin I
Solute Carrier
Slc1a4 L Solute carrier family 1 (glutamate/neutral amino acid transporter), member 4
Slc2a13 M Solute carrier family 2 (facilitated glucose transporter), member 13
Slc5a5 L Solute carrier family 5 (sodium iodide symporter), member 5
Slc6a2 M Solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2
Slc6a15 M Solute carrier family 6 (neutral amino acid transporter), member 15
Slc7a8 L Solute carrier family 7 (cationic amino acid transporter, yþ system), member 8
Slc8a3 M Solute carrier family 8 (sodium/calcium exchanger), member 3
Slc9a2 H Solute carrier family 9 (sodium/hydrogen exchanger), member 2
Slc9a4 M Solute carrier family 9 (sodium/hydrogen exchanger), member 4
Slc13a5 H Solute carrier family 13 (sodium-dependent citrate transporter), member 5
Slc25a1 L Solute carrier family 25 (mitochondrial carrier, citrate transporter), member 1
Slc26a2 L Solute carrier family 26 (sulfate transporter), member 2
Slc30a4 M Solute carrier family 30 (zinc transporter), member 4
Slc31a1 M Solute carrier family 31 (copper transporters), member 1
Slc35b1 L Solute carrier family 35, member B1
Slc36a1 M Solute carrier family 36 (proton/amino acid symporter), member 1
Slc36a2 H Solute carrier family 36 (proton/amino acid symporter), member 2
Slc39a7 M Solute carrier family 39 (zinc transporter), member 7
Slc39a8 M Solute carrier family 39 (metal ion transporter), member 8
Slco3a1 L Solute carrier organic anion transporter family, member 3a1
TGF-b signaling
Bambi M BMP and activin membrane–bound inhibitor
Bmp2 L Bone morphogenetic protein 2
Hnf4a L Hepatocyte nuclear factor 4, a
Inhba L Inhibin b-A
Nkx2-5 L NK2 transcription factor related, locus 5
Smad9 M SMAD family member 9
Tgfb1 L Transforming growth factor, b1
Tgfb3 L Transforming growth factor, b3
Vdr L Vitamin D (1,25-dihydroxyvitamin D3) receptor
Wnt/b-catenin signaling
Cdh2 M Cadherin 2
Cpz H Carboxypeptidase Z
Gja1 M Gap junction protein, a1
Kremen1 M Kringle-containing transmembrane protein 1
Wif1 M Wnt inhibitory factor 1
Wisp1 M Wnt1 inducible signaling pathway protein 1
Other
Ccnd1 M Cyclin D1
Creb3l1 H cAMP-responsive element–binding protein 3-like 1
Foxs1 L Forkhead box S1
Hif1a L Hypoxia-inducible factor 1, a subunit
Jund L Jun D protooncogene
Pthr1 M Parathyroid hormone receptor 1
Sox11 L SRY (sex-determining region Y)-box 11
Sp7 M Sp7 transcription factor (osterix)
H¼high-magnitude cluster; M¼medium-magnitude cluster; L¼low-magnitude cluster.
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(down). Genes within these clusters were grouped based on
functionand/orsignalingpathwaysusingIPA.Manygenegroups
known to be important in loading-induced bone formation were
identified, as were several novel gene groups whose function
with respect to bone formation is not known.
Early-response cluster
The early-response cluster was characterized primarily by genes
that showed increased expression 4hours after a single loading
session. It is known that gene expression of components in the
AP-1 transcription factor complex increases with mechanical
loading. Fosl1 and Junb genes were both upregulated shortly
after loading in our study and those of others,
(23,24) and Fosb
gene expression increased after loading and may be associated
with osteoblast differentiation and bone formation.
(25) Others
have observed increased protein expression of FOS and JUN
family members after loading in association with osteoblast
proliferation.
(26) JUND is one of the primary AP-1 signals when
osteoblasts are fully differentiated during matrix production and
mineralization, and JUND inhibits the S phase of the cell cycle.
(26)
Ourresults are consistent with thesefindings becauseJunD gene
expression increased during the matrix-formation phase, which
corresponded to the observation of differentiated osteoblasts on
the bone surface.
A group of chemokines was identified in the early-response
cluster and presents a potentially novel finding. Chemokines act
as chemotactic molecules for a number of different cell types.
Chemokines are known to be important in many biologic
functions, including development, immune function, and wound
repair.
(27) Many cytokines and chemokines that function in the
immune system regulate osteoblasts and osteoclasts,
(28) and
osteoblasts are known to produce both chemokines and their
receptors.
(29) The chemokine-related genes identified in our
study included a binding protein (Ccbp2), C–C motif ligands (Ccl2
and Ccl7), and C–X–C motif ligands (Cxcl1 and Cxcl13). CXCL13
upregulates alkaline phosphatase activity and also induces
release of b-N-acetylhexosaminidase, which is involved in bone
remodeling.
(30) There also was a group of chemokine-related
genes that were downregulated during matrix formation, which
included a C–C motif ligand (Ccl11), C–C motif receptors (Ccr1,
Ccr2, and Ccr3), a C–X–C motif ligand (Cxcl12), and a C–X–C motif
receptor (Cxcr5). Ligands that bind CCR1 are chemoattractants
that promote recruitment of marrow cells that can develop into
osteoclasts.
(31) CCR2 is expressed on osteoclasts,
(32) and CCR2
knockout mice have high bone mass, impaired osteoclast
function, and are resistant to ovariectomy-induced bone loss.
(33)
The receptor for CXCL13, CXCR5, is expressed in osteoblasts.
(30)
We postulate that chemokines in the early-response cluster may
be active shortly after a mechanical loading event to recruit
osteoblasts and/or osteoblast precursors to a site of bone
formation. However, later in the synthetic phase, additional
osteoblasts are not necessary, so chemokines may be down-
regulated. It is also possible that differential expression of
chemokines is related to the interaction of the bone cells and
immune cells. CXCL12 plays a role in fetal bone marrow
colonization,
(34,35) and interaction of CXCL12 and its receptor,
CXCR4, is necessary for retention of hematopoietic stem cells
(HSCs) in adult bone marrow.
(36,37) CXCL12/CXCR4 signaling
modulates bone resorption,
(38) osteoblast proliferation,
(39) and
priming of hematopoietic progenitor cells.
(40,41) In addition,
CXCL13/CXCR5 signaling is known to affect several aspects of B-
cell functionality.
(42,43)
A group of cytokines was present in the early-response cluster
as well. In bone, cytokines are usually associated with osteoclasts
and increased bone resorption. However, osteoclasts were not
observed in any of the histologic sections we analyzed.
Oncostatin M (OSM) is a cytokine that was shown recently to
inhibit Sost gene expression in primary calvarial osteoblasts, and
OSM treatment of calvariae in vivo enhanced bone formation.
(44)
In our study, Osm expression was highest at 4 hours and could
have contributed to decreased Sost expression during the
synthetic phase.
Matrix-formation (up) and matrix-formation (down)
clusters
Mostgenesexhibiteddifferentialexpressionduringthesynthetic
phase of bone formation and belonged to the matrix-formation
(up) and matrix-formation (down) clusters. The matrix-formation
(up) clusters were comprised of three groups that exhibited
different degrees of upregulation in response to loading, and the
matrix-formation (down) clusters were comprised of two groups
that were downregulated in response to loading. Matrix genes
dominated the upregulated clusters, whereas muscle-related
genes dominated the downregulated clusters. Several gene
groups were expressed in both up- and downregulated clusters,
including solute carriers, Wnt/b-catenin signaling, and TGF-b
signaling.
The largest group of upregulated genes identified in the
synthetic phase was associated with extracellular matrix and had
31 members, including proteoglycans, collagens, genes related
to collagen synthesis, osteoblast markers, matrix-related pro-
teins, and matrix metallopeptidases (MMPs). These groups of
genes are well known to be upregulated with mechanical
loading and bone formation. Probes targeting the Col1a1 gene
were not detected on the exon array platform, so Col1a1
expression was measured using qPCR. Col1a1 expression in
loaded ulnae followed a similar pattern as the genes in the
matrix-formation (up) clusters. A few matrix genes were part of
the matrix-formation (up) high-magnitude cluster, which had 23
total members and reached peak upregulation of approximately
4-fold at 12 days. Lox is important for collagen cross-linking, and
Cthrc1 and Lepre1 are associated with collagen synthesis. In
addition,this clusterincluded twoproteoglycans, Acan andVcan;
a metallopeptidase inhibitor, Timp1; and two minor collagens,
Col5a1 and Col11a2.
The second most abundant gene group in the matrix-
formation (up) clusters was comprised of solute carriers, which
have not been previously associated with mechanical loading.
Twenty solute carriers were upregulated by loading, and
examples of the types of molecules transported include amino
acids, glucose, and various ions. In addition, 15 solute carriers
were downregulated during matrix formation. Solute carriers
may be involved in supporting matrix synthesis by adjusting ion
GENE EXPRESSION IN BONE Journal of Bone and Mineral Research 107Table 3. Selected Gene Groups Present in the Bone-Formation (Down) Clusters, Which Were Downregulated During Matrix Formation
Gene group Cluster Gene name
Calcium signaling
Asph H Aspartate-b-hydroxylase
Cab39l L Calcium-binding protein 39-like
Calb2 H Calbindin 2
Camk2b H Calcium/calmodulin-dependent protein kinase (CaM kinase) IIb
Casq2 H Calsequestrin 2
Pvalb H Parvalbumin
Stc2 L Stanniocalcin 2
Trdn H Triadin
Cell cycle
Ccna2 L Cyclin A2
Ccnb1 L Cyclin B1
Cdc25b L Cell division cycle 25 homologue B
Cenpc1 L Centromere protein C1
Chemokine
Ccl11 L Chemokine (C–C motif) ligand 11
Ccr1 L Chemokine (C–C motif) receptor 1
Ccr2 L Chemokine (C–C motif) receptor 2
Ccr3 L Chemokine (C–C motif) receptor 3
Cxcl12 L Chemokine (C–X–C motif) ligand 12
Cxcl14 H Chemokine (C–X–C motif) ligand 14
Cxcr5 L Chemokine (C–X–C motif) receptor 5
Cytokine
Asb2 H Ankyrin repeat and SOCS box-containing 2
Il8rb L Interleukin 8 receptor, b
Tnfsf10 H Tumor necrosis factor (ligand) superfamily, member 10 (TRAIL)
Tnfrsf14 L Tumor necrosis factor receptor superfamily, member 14
Growth factor
Egf L Epidermal growth factor
Fgf1 L Fibroblast growth factor 1
Fgf7 H Fibroblast growth factor 7
Fgf23 H Fibroblast growth factor 23
Fgl2 H Fibrinogen-like 2
Hgf L Hepatocyte growth factor
Igfbp6 L Insulin-like growth factor–binding protein 6
Ion channel
Cacnb1 H Calcium channel, voltage-dependent, b1 subunit
Cacng1 H Calcium channel, voltage-dependent, g subunit 1
Cacng7 H Calcium channel, voltage-dependent, g subunit 7
Clca2 L Chloride channel calcium activated 2
Clic5 L Chloride intracellular channel 5
Hcn4 L Hyperpolarization activated cyclic nucleotide-gated potassium channel 4
Kcnj3 L Potassium inwardly rectifying channel, subfamily J, member 3
Kcnj11 H Potassium inwardly rectifying channel, subfamily J, member 11
Kcnj12 H Potassium inwardly rectifying channel, subfamily J, member 12
Kcnn4 L Potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4
Sclt1 L Sodium channel and clathrin linker 1
Scn4a H Sodium channel, voltage-gated, type 4, a subunit
Scn4b H Sodium channel, type IV, b
Scn7a L Sodium channel, voltage-gated, type VII, a
Matrix
Efemp1 H EGF-containing fibulin-like extracellular matrix protein 1
Mmp8 L Matrix metallopeptidase 8
Prelp L Proline arginine–rich end leucine-rich repeat protein
Serpinb2 L Serine (or cysteine) peptidase inhibitor, clade B, member 2
Spon1 L Spondin 1
(Continued)
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Gene group Cluster Gene name
Muscle
Acta1 H Actin, a1
Actn3 H Actinin, a3
Ampd1 H Adenosine monophosphate deaminase 1 (isoform M)
Des H Desmin
Dmd H Dystrophin, muscular dystrophy
Gyg1 H Glycogenin 1
Mb H Myoglobin
Myl1 H Myosin, light polypeptide 1
Mylk2 H Myosin light chain kinase 2
Mylpf H Myosin light chain, phosphorylatable, fast
Myocd H Myocardin
Smpx H Small muscle protein, X-linked
Synm H Synemin
Tnni2 H Troponin I type 2
Tnnt3 H Troponin T type 3
Tpm2 L Tropomyosin 2
Neurotransmitter
Chrna1 H Cholinergic receptor, nicotinic, a1
Chrnb1 H Cholinergic receptor, nicotinic, b1
Chrne H Cholinergic receptor, nicotinic, e
Htr1b L 5-Hydroxytryptamine (serotonin) receptor 1B
Maob L Monoamine oxidase B
Solute carrier
Slc2a1 H Solute carrier family 2 (facilitated glucose transporter), member 1
Slc4a1 L Solute carrier family 4 (anion exchanger), member 1
Slc6a4 L Solute carrier family 6 (neurotransmitter transporter, serotonin), member 4
Slc6a20 L Solute carrier family 6 (neurotransmitter transporter), member 20
Slc14a1 L Solute carrier family 14 (urea transporter), member 1
Slc15a2 L Solute carrier family 15 (H
þ/peptide transporter), member 2
Slc16a1 L Solute carrier family 16, member 1 (monocarboxylic acid transporter 1)
Slc16a3 H Solute carrier family 16, member 3 (monocarboxylic acid transporter 4)
Slc16a6 L Solute carrier family 16, member 6 (monocarboxylic acid transporter 7)
Slc22a3 H Solute carrier family 22 (extraneuronal monoamine transporter), member 3
Slc25a11 L Solute carrier family 25 (mitochondrial carrier, oxoglutarate carrier), member 11
Slc25a30 L Solute carrier family 25, member 30
Slc38a1 L Solute carrier family 38, member 1
Slc38a3 L Solute carrier family 38, member 3
Slco1a4 H Solute carrier organic anion transporter family, member 1a4
TGF-b signaling
Bmpr1b H Bone morphogenetic protein receptor, type IB
Chrdl1 L Chordin-like 1
Grem1 H Gremlin 1, cysteine knot superfamily
Tgfbr3 L Transforming growth factor, b receptor III
Ubiquitin
Usp1 L Ubiquitin-specific peptidase 1
Usp15 L Ubiquitin-specific peptidase 15
Wnt/b-catenin signaling (inhibitors)
Sfrp4 H Secreted frizzled-related protein 4
Sost L Sclerosteosis
Other
Adrb2 H Adrenergic, b2, receptor, surface
Casp1 L Caspase 1
Fcn1 L Ficolin (collagen/fibrinogen domain containing) 1
Lepr L Leptin receptor
Mustn1 L Musculoskeletal, embryonic nuclear protein 1
Ptgds2 L Prostaglandin D2 synthase 2, hematopoietic
Rsad2 L Radical S-adenosyl methionine domain containing 2
H¼high-magnitude cluster; L¼low-magnitude cluster.
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into the osteoblasts to facilitate matrix protein production.
In addition to gene groups, we identified signaling pathways
important in loading-induced bone formation. The Wnt/b-
catenin signaling pathway is known to play an integral role in
mechanotransduction and enhances the sensitivity of osteo-
blasts and osteocytes to loading.
(45) The matrix-formation (up)
clusters included several genes from the canonical Wnt pathway
and also included two inhibitors, Kremen1 and Wif1. Additionally,
two Wnt inhibitors, Sost and Sfrp4, were downregulated during
matrix formation. It was shown recently that Sost gene
expression decreased after in vivo bone loading and increased
with hind limb unloading.
(15) Thus, decreased expression of Sost
is associated with increased Wnt signaling and bone formation.
SFRP4 has not been as well studied. The Dkk1 gene encodes
another Wnt antagonist that has been shown previously to
decrease with loading,
(15) but probes targeting the Dkk1 gene
were not detected on the exon array platform used in our study.
We also observed increased Osm expression at early time points,
and this has been shown to contribute to decreased Sost
expression in bone.
(34) LRP5 is a Wnt coreceptor, and Wnt
signaling through LRP5 is required for mechanically induced
bone formation.
(45) In addition, it has been suggested that LRP5
may inhibit gut-derived serotonin synthesis, providing an
endocrine regulatory mechanism to increase bone mass.
(46)
Muscle genes were the largest group of downregulated genes
during matrix formation. This group was comprised mainly of
genes encoding muscle structural components and included
members of the actin, myosin, and troponin gene families. It is
important to note that all muscle was stripped from the ulnae
during dissection, so RNA was isolated from bone and marrow
only with no contamination from muscle. Therefore, these genes
were expressed in cells within the bone. Others have identified
muscle genes that were differentially expressed between
osteoblasts and osteocytes.
(47) Interestingly, 36 muscle-related
genes were downregulated in osteoblasts with respect to
osteocytes, including many of the same genes that were
downregulated with loading in our study (Acta1, Dmd, Myocd,
Myl1, Myplf, Tnni2, Tnnt3, and Tpm2).
(47) We speculate that our
finding that muscle-related genes are downregulated during
bone formation is congruent with the finding that muscle-
related genes are downregulated in osteoblasts compared with
osteocytes. Although the involvement of muscle-related genes
and proteins in bone biology is not well understood, it is clear
that they are highly regulated in bone cells.
The TGF-b pathway is important in loading-induced bone
formation,
(48,49) and many genes in the TGF-b superfamily were
upregulated during matrix formation. Two TGF-b superfamily
inhibitor genes (Chrdl1 and Grem1) weredownregulated. Overall,
it seems that signaling through the TGF-b pathway was
enhanced mostly by increasing expression of TGF-b inducers
anddecreasingexpressionofTGF-binhibitorsofboneformation.
A limitation of our approach is that because we isolated RNA
from the entire ulnar shaft, we cannot discern regional changes
in bone formation in response to loading. It is well documented
that mechanical loading elicits a regional bone-formation
response in the ulna loading model.
(4,14,50) Most of the bone
forms in the ulna midshaft on the periosteal surface, and greater
bone formation is observed on the medial surface than on the
lateral surface.
(14) In addition, since bone is deposited primarily
on the medial and lateral periosteal surfaces in the ulnar
midshaft, the geometric properties Imax and Imin change with
loading and are location-dependent. Imin increased significantly
in the ulnar midshaft, whereas Imax was moderately increased
with loading distally.
(4) In addition, we have completed a
computational model that was programmed to form bone in
regions that had greatest strain energy density.
(50) This
computational model almost perfectly mimicked the locations
of new bone formation measured in the ulna, thus showing that
there is a predictable pattern of bone formation in response to
loading.
In conclusion, we determined the time sequence of gene
expression in a bone subjected to mechanical loading, identified
groups of genes that shared a time-dependent gene expression
pattern, and determined which functions or pathways the genes
hadincommon.Weidentifiedsixclustersofgenesthatexhibited
unique expression patterns in response to loading over a time
course that captured key periods of the bone-formation process,
including expression of matrix-related genes, the appearance of
active osteoblasts, and bone desensitization. Many gene groups
known to be important in loading-induced bone formation were
identified within the clusters, including matrix, Wnt/b-catenin,
and TGF-b. Several novel gene groups were identified as well,
including chemokine, solute carrier, and muscle, whose func-
tions with respect to bone formation are not known.
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